Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, South Korea.
Department of Anesthesiology and Pain Medicine, Chung-Ang University College of Medicine, 102 Heukseok-ro, Heukseok-dong, Dongjak-gu, Seoul, 06973, South Korea.
Sci Rep. 2022 May 17;12(1):8130. doi: 10.1038/s41598-022-12374-3.
Flap failure after microvascular reconstructive surgery is a rare but devastating complication caused by reperfusion injury and tissue hypoperfusion. Remote ischemic conditioning (RIC) provides protection against ischemia/reperfusion injury and reduces tissue infarction. We hypothesized that RIC would enhance flap oxygenation and exert organ-protective effects during head and neck free flap reconstructive surgery. Adult patients undergoing free flap transfer surgery for head and neck cancer were randomized to receive either RIC or sham-RIC during surgery. RIC consisted of four cycles of 5-min ischemia and 5-min reperfusion applied to the upper or lower extremity. The primary endpoint, tissue oxygen saturation of the flap, was measured by near-infrared spectroscopy on the first postoperative day. Organ-protective effects of RIC were evaluated with infarct size of rat hearts perfused with plasma dialysate from patients received RIC or sham-RIC. Between April 2018 and July 2019, 50 patients were randomized (each n = 25) and 46 were analyzed in the RIC (n = 23) or sham-RIC (n = 23) groups. Tissue oxygen saturation of the flap was similar between the groups (85 ± 12% vs 83 ± 9% in the RIC vs sham-RIC groups; P = 0.471). Myocardial infarct size after treatment of plasma dialysate was significantly reduced in the RIC group (44 ± 7% to 26 ± 6%; P = 0.018) compared to the sham-RIC group (42 ± 6% to 37 ± 7%; P = 0.388). RIC did not improve tissue oxygenation of the transferred free flap in head and neck cancer reconstructive surgery. However, there was evidence of organ-protective effects of RIC in experimental models.Trial registration: Registry number of ClinicalTrials.gov: NCT03474952.
微血管重建手术后皮瓣失败是一种罕见但破坏性的并发症,由再灌注损伤和组织灌注不足引起。远程缺血预处理 (RIC) 可提供对缺血/再灌注损伤的保护作用,并减少组织梗死。我们假设 RIC 将增强皮瓣的氧合作用,并在头颈部游离皮瓣重建手术中发挥器官保护作用。接受头颈部癌症游离皮瓣转移手术的成年患者被随机分为手术期间接受 RIC 或假 RIC。RIC 由四个 5 分钟缺血和 5 分钟再灌注循环组成,施加在上肢或下肢。皮瓣组织氧饱和度作为主要终点,通过近红外光谱术在术后第一天进行测量。RIC 的器官保护作用通过接受 RIC 或假 RIC 的患者的血浆透析液灌注的大鼠心脏梗死面积来评估。2018 年 4 月至 2019 年 7 月,50 名患者被随机分组(每组 n=25),46 名患者纳入 RIC(n=23)或假 RIC(n=23)组。两组皮瓣组织氧饱和度相似(RIC 组 85±12%,假 RIC 组 83±9%;P=0.471)。RIC 组处理后的血浆透析液心肌梗死面积明显减少(44±7%至 26±6%;P=0.018),与假 RIC 组相比(42±7%至 37±7%;P=0.388)。RIC 未改善头颈部癌症重建手术中转移游离皮瓣的组织氧合作用。然而,RIC 在实验模型中具有器官保护作用的证据。试验注册:ClinicalTrials.gov 注册号:NCT03474952。